Dicloxacillin

DRUG7 trials

Conditions

BacteremiaBacterial InfectionsDrug-drug InteractionEndocarditis InfectiveGram-Positive Bacterial InfectionsHealthyHealthy VolunteersPeriprosthetic joint infection

Phase 1

Dicloxacillin: Clinical Relevance of Drug-drug Interactions by Induction of Drug Metabolism.

CompletedNCT02983890

Per DamkierHealthy

Start: 2016-10-06End: 2017-10-01Updated: 2018-08-23

The Effect of Dicloxacillin on Oral Absorption of Drugs

CompletedNCT05073627

University of Southern DenmarkDrug-drug Interaction, Healthy Volunteers

Start: 2022-02-07End: 2022-06-22Updated: 2022-07-21

Phase 3

Antibiotic Treatment for Infections of Short Term In-dwelling Vascular Catheters Due to Gram Positive Bacteria

CompletedNCT00037050

PfizerBacteremia, Bacterial Infections, Gram-Positive Bacterial Infections

Start: 2002-04-30End: 2005-07-31Updated: 2009-09-14

Phase 4

Oral Antimicrobial Treatment vs. Outpatient Parenteral for Infective Endocarditis

RecruitingNCT05398679

Fundacion Clinic per a la Recerca BiomédicaEndocarditis Infective

Start: 2022-08-17End: 2027-12-30Target: 360Updated: 2026-02-25

Early shift to oral antibiotic treatment of pyogenic vertebral osteomyelitis – a open label non-inferiority randomized nationwide study.

RecruitingCTIS2023-507617-96-01

RigshospitaletPyogenic vertebral osteomyelitis

Start: 2024-02-14Target: 530Updated: 2025-01-08

The DALBA-study Introduction of the antibiotic dalbavancin in orthopaedic surgery – an evaluation of: • Health economic costs • Patient-reported outcomes on quality of life • Local bone and soft tissue concentrations • Effect on the gut microbiome A randomised controlled study of dalbavancin versus standard antibiotic treatment of Gram-positive periprosthetic joint infections.

RecruitingCTIS2025-522088-13-00

Region MidtjyllandPeriprosthetic joint infection

Start: 2025-12-12Target: 50Updated: 2025-12-05

Unknown Phase

Determinants of Warfarin Metabolism

RecruitingNCT00162474

Hadassah Medical OrganizationHealthy

Start: 2003-09-01End: 2030-12-01Target: 1000Updated: 2026-04-21

Related Papers

Early shift to oral antibiotic treatment for pyogenic vertebral osteomyelitis (SAVE): study protocol for an open label, non-inferiority, nation-wide randomized controlled clinical trial.

2025-12-10

Oral vs. Outpatient Parenteral Antimicrobial Treatment for Infective Endocarditis: Study Protocol for the Spanish OraPAT-IE GAMES Trial

Infectious Diseases and Therapy2025-03-014 citations

Quantitative Assessment of CYP2C9 Genetic Polymorphisms Effect on the Oral Clearance of S-Warfarin in Healthy Subjects.

2017-02-015 citations